KALAMAZOO, Mich. – Patients tested for vascular disease at Bronson receive a high level of patient care and quality diagnosis testing, according to the Accreditation of Vascular Laboratories (ICAVL). The organization recognized the Bronson Non Invasive Vascular Laboratory with a three-year accreditation for its noninvasive testing standards.
Cardiovascular disease is the leading cause of death in the United States, costing more than $83.7 billion each year in health services, medications and lost work time due to disability. One American dies every 32 seconds from cardiovascular disease, disorders of the heart and blood vessels. Each year, 2 million people in the United States alone develop deep vein thrombosis – blood clots in the veins. This affliction becomes life threatening for 500,000 of those people when the blood clot breaks loose and travels to the lungs.
Early detection of these life-threatening vascular diseases is possible through the use of noninvasive vascular testing techniques performed within vascular laboratories.
Bronson is one of a select number of vascular laboratories in the United States, Canada and Puerto Rico to meet or exceed the ICAVL standards. Participation in the accreditation process demonstrates the laboratory’s attention to a high level of patient care and quality testing.
About the ICAVL
The ICAVL is a non-profit organization established with the support of 11 medical societies, including physicians, technologists and sonographers that represent medical specialties including cardiology, neurology, radiology, vascular medicine, vascular surgery, neurosurgery, internal medicine, and biology.
Looking for a Bronson doctor? Find the perfect fit for you.
Help Bronson support our community with a monetary donation.